Search

Padmavathy A Vanguri

from Saint Cloud, FL
Age ~68
Get Report
Also known as:
Padmavath Vanguri, Pras Vanguri, Prasanna Vanguri
Related to:
Apparao N VanguriPrasanna R Vanguri, 38Poornima Vanguri, 41
Connected to:
Neelima Vanguri, 40Manohar Vanguru, 45Fred W Vanhaaften, 83Amanda M Vanhaaren, 43Bruno E Vanhaelst, 56Stephen A Vanhaerents, 41Charlie Vanhagar, 66Brad L Vanhaitsma, 51John D Vanhaitsma, 77Karen L Vanhaitsma, 63

Padmavathy Vanguri Phones & Addresses

  • Saint Cloud, FL
  • Baltimore, MD
  • Reisterstown, MD
  • 1 Ivy Reach Ct, Cockeysville, MD 21030 (410) 252-4440
  • 12330 Happy Hollow Rd, Cockeysville, MD 21030 (410) 252-4440
  • Cockysvil, MD

Resumes

Resumes

Padmavathy Vanguri Photo 1

Padmavathy Vanguri

View page
Location:
Baltimore, MD
Industry:
Biotechnology
Education:
University of Maryland School of Medicine 1982 - 1987
University of Maryland School of Medicine;;1982 – 1987;
University of Maryland School of Medicine
Padmavathy Vanguri Photo 2

Associate Director Ms And T

View page
Location:
Baltimore, MD
Industry:
Biotechnology
Work:
Windmil Therapeutics
Associate Director Ms and T
Lonza Jan 2012 - Dec 2015
Senior Manager, Cell Culture Technologies, Cell Therapy Process Development
Lonza 2008 - Dec 2011
Section Manager, Technology Transfer, Cell Systems
Theradigm 2002 - 2006
Director Neurobiology
Osiris Therapeutics 2000 - 2002
Senior Manager, Gene Delivery
Education:
University of Maryland School of Medicine 1982 - 1987
Doctorates, Doctor of Philosophy, Immunology, Medicine
Skills:
Cell Culture
Cell
Stem Cells
R&D
Technology Transfer
Gene Therapy
Cell Therapy
Biotechnology
Elisa
Molecular Biology
Cell Biology
Biochemistry
Glp
Pcr
Immunology
Gmp
Assay Development
Sop
Cell Therapy Process Development
Scale Up Cell Manufacture
Lifesciences
Life Sciences

Publications

Us Patents

Immunocompetent Animals Including Xenogeneic Implants Of Mesenchymal Stem Cells

View page
US Patent:
20020129392, Sep 12, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/992229
Inventors:
Padmavathy Vanguri - Cockeysville MD, US
Robert Deans - Claremont CA, US
Assignee:
Osiris Therapeutics, Inc.
International Classification:
A01K067/027
US Classification:
800/014000, 800/018000, 800/003000
Abstract:
An immunocompetent post-natal animal of a first species having had administered thereto, such as by implantation or injection, mesenchymal stem cells which were obtained from an animal of a second species. In one embodiment, an immunocompetent mouse has human mesenchymal stem cells implanted therein.

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells

View page
US Patent:
20040033217, Feb 19, 2004
Filed:
May 28, 2003
Appl. No.:
10/446450
Inventors:
Padmavathy Vanguri - Cockeysville MD, US
Joseph Mosca - Ellicott City MD, US
International Classification:
A61K048/00
C12N005/08
US Classification:
424/093210, 435/366000
Abstract:
A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.

Compositions And Methods Relating To Culturing Neural Stem Cells With Bone Marrow Stromal Cells

View page
US Patent:
20050176141, Aug 11, 2005
Filed:
Feb 1, 2005
Appl. No.:
11/048581
Inventors:
Padmavathy Vanguri - Cockeysville MD, US
International Classification:
C12N005/08
C12N005/02
US Classification:
435368000, 435372000, 435404000
Abstract:
The present invention encompasses methods and compositions for enhancing the growth of neural stem cells. Methods for modulating MHC molecule expression on a neural stem cell (NSC) are also included in the invention.

Expansion Of Neural Stem Cells With Lif

View page
US Patent:
20050214941, Sep 29, 2005
Filed:
Mar 16, 2005
Appl. No.:
11/083231
Inventors:
Smita Bhonsale - Ellicott City MD, US
Padmavathy Vanguri - Cockeysville MD, US
International Classification:
C12N005/08
US Classification:
435368000
Abstract:
The present invention encompasses methods and compositions for enhancing the growth of neural stem cells (NSCs).

Adipose Tissue Derived Stromal Cells For The Treatment Of Neurological Disorders

View page
US Patent:
20070104697, May 10, 2007
Filed:
Nov 23, 2005
Appl. No.:
11/286900
Inventors:
William Wilkison - Durham NC, US
Jeffrey Gimble - Baton Rouge LA, US
Padmavathy Vanguri - Cockeysville MD, US
International Classification:
A61K 48/00
A61K 35/30
US Classification:
424093210, 424093700
Abstract:
The present invention relates to a treatment of neural injury and neurodegenerative diseases. Also included in the present invention is the use of adipose tissue derived stromal cells for the treatment of neural injury (stroke, traumatic brain injury, spinal cord injury) and neurodegeneration (i.e. Parkinson's disease).

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells

View page
US Patent:
20090238802, Sep 24, 2009
Filed:
Jan 28, 2009
Appl. No.:
12/360913
Inventors:
Padmavathy Vanguri - Cockeysville MD, US
Joseph D. Mosca - Ellicott City MD, US
International Classification:
A61K 35/12
A61P 3/00
US Classification:
424 937
Abstract:
A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.

Intraperitoneal Delivery Of Genetically Engineered Mesenchymal Stem Cells

View page
US Patent:
20090257989, Oct 15, 2009
Filed:
May 1, 2009
Appl. No.:
12/433970
Inventors:
Padmavathy Vanguri - Cockeysville MD, US
Joseph D. Mosca - Ellicott City MD, US
International Classification:
A61K 45/00
A61P 19/02
US Classification:
424 937
Abstract:
A method of expressing at least one protein in an animal by intraperitoneal administration of mesenchymal stem cells genetically engineered with at least one polynucleotide encoding the at least one protein. The method may be employed in treating lysosomal storage disorders, such as Fabry Disease, or arthritic disorders, or hemophilia, for example.

Adipose Tissue Derived Stromal Cells For The Treatment Of Neurological Disorders

View page
US Patent:
20100119496, May 13, 2010
Filed:
Aug 7, 2009
Appl. No.:
12/537883
Inventors:
William O. Wilkison - Durham NC, US
Jeffrey M. Gimble - Baton Rouge LA, US
Padmavathy Vanguri - Cockeysville MD, US
Assignee:
ARTECEL, INC. - Bethesda MD
International Classification:
A61K 35/12
A61P 25/00
US Classification:
424 9321, 424 937, 435366
Abstract:
The present invention relates to a treatment of neural injury and neurodegenerative diseases. Also included in the present invention is the use of adipose tissue derived stromal cells for the treatment of neural injury (stroke, traumatic brain injury, spinal cord injury) and neurodegeneration (i.e. Parkinson's disease).
Control profile
Padmavathy A Vanguri from Saint Cloud, FL, age ~68 Get Report